AnaptysBio, Inc.
PD-1 AGONIST AND METHOD OF USING SAME

Last updated:

Abstract:

Provided is a PD-1-binding agent comprising an immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide, as well as related compositions and methods for making and using same.

Status:
Application
Type:

Utility

Filling date:

4 Jun 2020

Issue date:

28 Jul 2022